Literature DB >> 9311737

Hereditary nonpolyposis colorectal cancer families not complying with the Amsterdam criteria show extremely low frequency of mismatch-repair-gene mutations.

J Wijnen1, P M Khan, H Vasen, H van der Klift, A Mulder, I van Leeuwen-Cornelisse, B Bakker, M Losekoot, P Møller, R Fodde.   

Abstract

Hereditary nonpolyposis colorectal cancer (HNPCC) is a common autosomal dominant cancer-susceptibility condition characterized by early onset colorectal cancer. Germ-line mutations in one of four DNA mismatch repair (MMR) genes, hMSH2, hMLH1, hPMS1, or hPMS2, are known to cause HNPCC. Although many mutations in these genes have been found in HNPCC kindreds complying with the so-called Amsterdam criteria, little is known about the involvement of these genes in families not satisfying these criteria but showing clear-cut familial clustering of colorectal cancer and other cancers. Here, we applied denaturing gradient-gel electrophoresis to screen for hMSH2 and hMLH1 mutations in two sets of HNPCC families, one set comprising families strictly complying with the Amsterdam criteria and another set in which at least one of the criteria was not satisfied. Interestingly, hMSH2 and hMLH1 mutations were found in 49% of the kindreds fully complying with the Amsterdam criteria, whereas a disease-causing mutation could be identified in only 8% of the families in which the criteria were not satisfied fully. In correspondence with these findings, 4 of 6 colorectal tumors from patients belonging to kindreds meeting the criteria showed microsatellite instability, whereas only 3 of 11 tumors from the other set of families demonstrated this instability. Although the number of tumors included in the study admittedly is small, the frequencies of mutations in the MMR genes show obvious differences between the two clinical sets of families. These results also emphasize the practical importance of the Amsterdam criteria, which provide a valid clinical subdivision between families, on the basis of their chance of carrying an hMSH2 or an hMLH1 mutation, and which bear important consequences for genetic testing and counseling and for the management of colorectal cancer families.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9311737      PMCID: PMC1715907          DOI: 10.1086/514847

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  29 in total

1.  Microsatellite instability and mutation analysis of hMSH2 and hMLH1 in patients with sporadic, familial and hereditary colorectal cancer.

Authors:  G Moslein; D J Tester; N M Lindor; R Honchel; J M Cunningham; A J French; K C Halling; M Schwab; P Goretzki; S N Thibodeau
Journal:  Hum Mol Genet       Date:  1996-09       Impact factor: 6.150

2.  DNA mismatch repair gene mutations in 55 kindreds with verified or putative hereditary non-polyposis colorectal cancer.

Authors:  M Nyström-Lahti; Y Wu; A L Moisio; R M Hofstra; J Osinga; J P Mecklin; H J Järvinen; J Leisti; C H Buys; A de la Chapelle; P Peltomäki
Journal:  Hum Mol Genet       Date:  1996-06       Impact factor: 6.150

3.  Detection and localization of single base changes by denaturing gradient gel electrophoresis.

Authors:  R M Myers; T Maniatis; L S Lerman
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

4.  Accumulation of multiple mutations in tumour suppressor genes during colorectal tumorigenesis in HNPCC patients.

Authors:  V Lazar; S Grandjouan; C Bognel; D Couturier; P Rougier; D Bellet; B Bressac-de Paillerets
Journal:  Hum Mol Genet       Date:  1994-12       Impact factor: 6.150

5.  Genomic structure of human mismatch repair gene, hMLH1, and its mutation analysis in patients with hereditary non-polyposis colorectal cancer (HNPCC)

Authors:  H J Han; M Maruyama; S Baba; J G Park; Y Nakamura
Journal:  Hum Mol Genet       Date:  1995-02       Impact factor: 6.150

6.  Majority of hMLH1 mutations responsible for hereditary nonpolyposis colorectal cancer cluster at the exonic region 15-16.

Authors:  J Wijnen; P M Khan; H Vasen; F Menko; H van der Klift; M van den Broek; I van Leeuwen-Cornelisse; F Nagengast; E J Meijers-Heijboer; D Lindhout; G Griffioen; A Cats; J Kleibeuker; L Varesco; L Bertario; M L Bisgaard; J Mohr; R Kolodner; R Fodde
Journal:  Am J Hum Genet       Date:  1996-02       Impact factor: 11.025

7.  Analysis of mismatch repair genes in hereditary non-polyposis colorectal cancer patients.

Authors:  B Liu; R Parsons; N Papadopoulos; N C Nicolaides; H T Lynch; P Watson; J R Jass; M Dunlop; A Wyllie; P Peltomäki; A de la Chapelle; S R Hamilton; B Vogelstein; K W Kinzler
Journal:  Nat Med       Date:  1996-02       Impact factor: 53.440

8.  Seven new mutations in hMSH2, an HNPCC gene, identified by denaturing gradient-gel electrophoresis.

Authors:  J Wijnen; H Vasen; P M Khan; F H Menko; H van der Klift; C van Leeuwen; M van den Broek; I van Leeuwen-Cornelisse; F Nagengast; A Meijers-Heijboer
Journal:  Am J Hum Genet       Date:  1995-05       Impact factor: 11.025

9.  Microsatellite instability and mutations of the transforming growth factor beta type II receptor gene in colorectal cancer.

Authors:  R Parsons; L L Myeroff; B Liu; J K Willson; S D Markowitz; K W Kinzler; B Vogelstein
Journal:  Cancer Res       Date:  1995-12-01       Impact factor: 12.701

10.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

View more
  50 in total

1.  Three novel missense germline mutations in different exons of MSH6 gene in Chinese hereditary non-polyposis colorectal cancer families.

Authors:  Shi-Yan Yan; Xiao-Yan Zhou; Xiang Du; Tai-Ming Zhang; Yong-Ming Lu; San-Jun Cai; Xiao-Li Xu; Bao-Hua Yu; Heng-Hua Zhou; Da-Ren Shi
Journal:  World J Gastroenterol       Date:  2007-10-07       Impact factor: 5.742

2.  Lynch Syndrome in high risk Ashkenazi Jews in Israel.

Authors:  Yael Goldberg; Inbal Kedar; Revital Kariiv; Naama Halpern; Morasha Plesser; Ayala Hubert; Luna Kaduri; Michal Sagi; Israela Lerer; Dvorah Abeliovich; Tamar Hamburger; Aviram Nissan; Hanoch Goldshmidt; Irit Solar; Ravit Geva; Hana Strul; Guy Rosner; Hagit Baris; Zohar Levi; Tamar Peretz
Journal:  Fam Cancer       Date:  2014-03       Impact factor: 2.375

3.  RNA analysis of cancer predisposing genes in formalin-fixed paraffin-embedded tissue determines aberrant splicing.

Authors:  Anne Ml Jansen; Heleen M van der Klift; Marieke Ae Roos; Jaap Dh van Eendenburg; Carli Mj Tops; Juul T Wijnen; Frederik J Hes; Hans Morreau; Tom van Wezel
Journal:  Eur J Hum Genet       Date:  2018-04-30       Impact factor: 4.246

4.  Mutational analysis of hMsh6 in Israeli HNPCC and HNPCC-like families.

Authors:  Shiri Dovrat; Arie Figer; Herma H Fidder; Pavlos Neophytou; Zvi Fireman; Ravit Geva; Jamal Zidan; Dov Flex; Shimon Bar Meir; Eitan Friedman
Journal:  Fam Cancer       Date:  2005       Impact factor: 2.375

5.  Geno- and pheno-typic characterization in ten patients with double-primary gastric and colorectal adenocarcinomas.

Authors:  Jin C Kim; Kum H Koo; Hee C Kim; Jung S Kim; Gyeong H Kang
Journal:  Int J Colorectal Dis       Date:  2004-04-09       Impact factor: 2.571

6.  Cancer risks for MLH1 and MSH2 mutation carriers.

Authors:  James G Dowty; Aung K Win; Daniel D Buchanan; Noralane M Lindor; Finlay A Macrae; Mark Clendenning; Yoland C Antill; Stephen N Thibodeau; Graham Casey; Steve Gallinger; Loic Le Marchand; Polly A Newcomb; Robert W Haile; Graeme P Young; Paul A James; Graham G Giles; Shanaka R Gunawardena; Barbara A Leggett; Michael Gattas; Alex Boussioutas; Dennis J Ahnen; John A Baron; Susan Parry; Jack Goldblatt; Joanne P Young; John L Hopper; Mark A Jenkins
Journal:  Hum Mutat       Date:  2013-03       Impact factor: 4.878

7.  Frequency of replication errors in colorectal cancer and their association with family history.

Authors:  S R Brown; P J Finan; L Cawkwell; P Quirke; D T Bishop
Journal:  Gut       Date:  1998-10       Impact factor: 23.059

8.  Mutation spectrum in HNPCC in the Israeli population.

Authors:  Yael Goldberg; Rinnat M Porat; Inbal Kedar; Chen Shochat; Michal Sagi; Avital Eilat; Suzan Mendelson; Tamar Hamburger; Aviram Nissan; Ayala Hubert; Luna Kadouri; Eli Pikarski; Israela Lerer; Dvorah Abeliovich; Dani Bercovich; Tamar Peretz
Journal:  Fam Cancer       Date:  2008-04-04       Impact factor: 2.375

9.  Genomic instability and carcinogenesis: an update.

Authors:  Wael M Abdel-Rahman
Journal:  Curr Genomics       Date:  2008-12       Impact factor: 2.236

10.  Performance of clinical guidelines compared with molecular tumour screening methods in identifying possible Lynch syndrome among colorectal cancer patients: a Norwegian population-based study.

Authors:  G Tranø; W Sjursen; H H Wasmuth; E Hofsli; L J Vatten
Journal:  Br J Cancer       Date:  2010-01-05       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.